Evan Vosburgh - Concepedia

Author

Evan Vosburgh

Boston University ORCID

Also Known As

E Vosburgh, E. Vosburgh, EVAN VOSBURGH, Evan Vosburgh, Evan Vosburgh And

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Boston University Rutgers, The State University of New Jersey Institute for Advanced Study Memorial Sloan Kettering Cancer Center Boston Medical Center

About

Evan Vosburgh is an author at Boston University specializing in medicine, tumor biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	211
2	Cell Biology	2	2	48
3	Engineering	1	1	115
4	Biology	1	1	128
5	Biomedical Engineering	1	1	115

Evan Vosburgh

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Dose-Intensive Melphalan With Blood Stem-Cell Support for the Treatment of AL (Amyloid Light-Chain) Amyloidosis: Survival and Responses in 25 Patients Raymond L. Comenzo, Evan Vosburgh, Rodney H. Falk, Blood	1998	342
Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients R Comenzo, Evan Vosburgh, RW Simms, Blood	1996	229
Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding M. H. Lee, Evan Vosburgh, K. C. Anderson, Blood	1993	130
Coupled sodium-chloride influx across brush border of flounder intestine Raymond A. Frizzell, Philip L. Smith, Evan Vosburgh, The Journal of Membrane Biology BiologyAquatic OrganismBrush Border	1979	128
Sucrose Formulated Recombinant Human Antihemophilic Factor VIII Is Safe and Efficacious for Treatment of Hemophilia A in Home Therapy Eduard Gorina, E. Kellermann, Evan Vosburgh, Thrombosis and Haemostasis	2000	124
High-throughput Image Analysis of Tumor Spheroids: A User-friendly Software Application to Measure the Size of Spheroids Automatically and Accurately Wenjin Chen, Chung F. Wong, Evan Vosburgh, Journal of Visualized Experiments EngineeringDigital PathologyPathologyBiomedical EngineeringTumor Spheroids	2014	115
Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura Mark Weinstein, Rita A. Blanchard, J.L. Moake, British Journal of Haematology	1989	109
Intermediate‐dose intravenous melphalan and blood stem cells mobilized with sequential GM+G‐CSF or G‐CSF alone to treat AL (amyloid light chain) amyloidosis Raymond L. Comenzo, Vaishali Sanchorawala, CATHERINE FISHER, British Journal of Haematology	1999	73
The bromodomain and extra-terminal inhibitor CPI203 enhances the antiproliferative effects of rapamycin on human neuroendocrine tumors Chung F. Wong, Saurabh V. Laddha, Laura H. Tang, Cell Death and Disease	2014	56
Two well-differentiated pancreatic neuroendocrine tumor mouse models Chung Wong, Laura H. Tang, Christian J. Davidson, Cell Death and Differentiation	2019	53

Page 1